Sen. Villa supports SB3049 to broaden scope and rename newborn screening advisory group

During the 104th General Assembly on May 31, 2026, Sen. Karina Villa (D-25th) voted Yes on SB3049, a measure that would both rename and enlarge the Universal Newborn Screening Advisory Committee. According to the Illinois Senate, the bill passed with a unanimous 54-0 vote.

As outlined in the official bill text, the act is captioned: "NEWBORN METABOLIC SCREENING."

The following summary is derived from the actual bill text, with interpretations provided to offer clearer understanding of the bill's terms.

This legislation renames the Genetic and Metabolic Diseases Advisory Committee as the Universal Newborn Screening Advisory Committee, while expanding its authority to oversee Illinois’ newborn screening program. The committee is required to meet quarterly beginning July 1, 2026, regularly consider medical conditions meeting federal or treatment-based criteria, and specifically assess multiple rare disorders, such as certain mucopolysaccharidoses and Batten disease type 2, for possible addition to the screening program. The new statute establishes deadlines for ongoing reviews, state decisions, laboratory adjustments, public annual reports, and harmonizes related laws, including the Rare Disease Commission Act. The law is effective immediately.

The final action for SB3049 was recorded as 'House Committee Amendment No. 1 Senate Concurs.'

A member of the Democratic Party, Villa was elected to represent Illinois' 25th Senate District in 2021, taking office following Jim Oberweis.

To become law in Illinois, proposed bills advance through a multi-step legislative process involving introduction, committee review, debates, and votes in both chambers before the governor makes the final decision. The General Assembly operates on a biennial basis, with thousands of bills filed each session, though only a limited number make it through the full legislative process.